Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$75,000.00

Involvement of cellular alternative splicing in the oncolytic potential of viruses for cancer therapy

EF 2024-25

Résumé
Cancer is the leading cause of death in Canada. Although significant progress has been made in recent years in terms of treatments, the search for new cancer therapies is an ongoing endeavour required to enhance the survival of patients and provide new therapeutic opportunities with less secondary effects. Viruses that replicate preferentially in cancer cells and destroy them provide a new promising opportunity in our fight against cancer. However, even though initial clinical trials have generated promising results, larger clinical trials revealed a limited efficacy of these viruses. Thus, a better understanding of how these viruses function and ways to potentiate their anticancer activity is required. We propose to study the importance of regulation of RNA processing in the anticancer activity of these viruses. Dysregulation in RNA processing has been well documented in cancer for more than 20 years, and it is now clear that viruses alter RNA processing in cells to promote viral replication. Moreover, recent evidence suggests cancer-specific dysregulation in RNA processing is a therapeutic vulnerability that we believe can be harnessed to improve the treatment of cancer. This research proposal will leverage the power of high-throughput screening to identify cellular proteins involved in RNA processing that can be targeted to improve the replication and killing of cancer cells by viruses. Moreover, we will also identify small molecules that alter RNA processing which can potentiate the therapeutic potential of these viruses. Finally, we will fundamentally investigate the impact of one of these viruses on RNA processing during infection and the importance of this dysregulation in its ability to destroy cancer cells. This research proposal will potentially lead to new ways to enhance the therapeutic potential of viruses in the treatment of cancer based on the manipulation of RNA processing in cancer cells.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Pennsylvania, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
512566
Name
Boudreault Simon
Region
Pennsylvania
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Involvement of cellular alternative splicing in the oncolytic potential of viruses for cancer therapy
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Alternative Splicing; Cancer; Oncolytic Virus; Rna-Seq; Sirna Screen; Spliceosomal Proteins; Spliceosome; Splicing; Splicing Factors; Xenograft
Abstract
Cancer is the leading cause of death in Canada. Although significant progress has been made in recent years in terms of treatments, the search for new cancer therapies is an ongoing endeavour required to enhance the survival of patients and provide new therapeutic opportunities with less secondary effects. Viruses that replicate preferentially in cancer cells and destroy them provide a new promising opportunity in our fight against cancer. However, even though initial clinical trials have generated promising results, larger clinical trials revealed a limited efficacy of these viruses. Thus, a better understanding of how these viruses function and ways to potentiate their anticancer activity is required. We propose to study the importance of regulation of RNA processing in the anticancer activity of these viruses. Dysregulation in RNA processing has been well documented in cancer for more than 20 years, and it is now clear that viruses alter RNA processing in cells to promote viral replication. Moreover, recent evidence suggests cancer-specific dysregulation in RNA processing is a therapeutic vulnerability that we believe can be harnessed to improve the treatment of cancer. This research proposal will leverage the power of high-throughput screening to identify cellular proteins involved in RNA processing that can be targeted to improve the replication and killing of cancer cells by viruses. Moreover, we will also identify small molecules that alter RNA processing which can potentiate the therapeutic potential of these viruses. Finally, we will fundamentally investigate the impact of one of these viruses on RNA processing during infection and the importance of this dysregulation in its ability to destroy cancer cells. This research proposal will potentially lead to new ways to enhance the therapeutic potential of viruses in the treatment of cancer based on the manipulation of RNA processing in cancer cells.
Competitiondate
202410
Approvedterm2
1 yr 0 mth
Pinamesdelim
Boudreault, Simon
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $75,000~ $0~